Save time and get answers to complex questions with AI chat
Generic brand for latisse?Novartis patent term dabrafenib?Are there income restrictions for lipitor's patient program?Diltiazem drug class?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for spravato
Yes. Spravato (esketamine) is used to treat certain types of depression, specifically treatment-resistant depression and depressive episodes in adults with major depressive disorder who also have acute suicidal ideation or behavior. [1]
Spravato is indicated for: - Treatment-resistant depression in adults [1] - Major depressive disorder with acute suicidal ideation or behavior in adults [1]
Spravato is typically used in combination with an oral antidepressant for the approved depression indications. [1]
Spravato is not described as a general antidepressant for all types of depression. Its approved use is limited to the specific adult depression groups above (treatment-resistant depression, and major depressive disorder with acute suicidal ideation or behavior). [1]
Spravato is administered under healthcare supervision with monitoring, which is part of how the treatment is delivered for its approved depression indications. [1]
Other Questions About Spravato :